CommercialCoverageMedium impact
06.02.31g, Genetic Testing for Congenital Long QT Syndrome (Independence Administrators)
Independence Blue Cross·Cardiology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
Independence Administrators has reissued their genetic testing policy for Congenital Long QT Syndrome, effective March 5, 2025. This policy reissuance may include updates to coverage criteria, prior authorization requirements, or documentation standards for genetic testing related to this cardiac condition.
Action Required
By March 5, 2025: Billing team should review the complete updated policy 06.02.31g for genetic testing for Congenital Long QT Syndrome on the Independence Administrators website. Verify any changes to prior authorization requirements, coverage criteria, or documentation standards for genetic testing claims. Update billing procedures and encounter forms if new requirements are identified.